Trust Co. of Vermont reduced its holdings in Cigna Group (NYSE:CI - Free Report) by 7.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,047 shares of the health services provider's stock after selling 1,411 shares during the quarter. Trust Co. of Vermont's holdings in Cigna Group were worth $5,608,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in CI. Two Sigma Investments LP lifted its position in shares of Cigna Group by 32.6% during the 4th quarter. Two Sigma Investments LP now owns 764,900 shares of the health services provider's stock valued at $211,219,000 after acquiring an additional 188,235 shares during the last quarter. Humankind Investments LLC lifted its holdings in shares of Cigna Group by 12.1% during the fourth quarter. Humankind Investments LLC now owns 5,294 shares of the health services provider's stock valued at $1,462,000 after purchasing an additional 571 shares during the last quarter. NBC Securities Inc. acquired a new position in shares of Cigna Group in the 1st quarter valued at $123,000. First American Trust FSB purchased a new position in Cigna Group in the 4th quarter worth about $4,471,000. Finally, Factorial Partners LLC raised its holdings in Cigna Group by 7.8% during the 4th quarter. Factorial Partners LLC now owns 12,450 shares of the health services provider's stock worth $3,438,000 after buying an additional 900 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.
Cigna Group Stock Performance
Shares of Cigna Group stock traded up $3.81 during midday trading on Monday, hitting $330.12. The company had a trading volume of 3,422,685 shares, compared to its average volume of 1,834,802. The stock has a market cap of $88.19 billion, a PE ratio of 18.28, a P/E/G ratio of 0.97 and a beta of 0.44. Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The business's 50 day simple moving average is $320.64 and its two-hundred day simple moving average is $308.08. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.72 and a quick ratio of 0.72.
Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating the consensus estimate of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The business had revenue of $65.45 billion during the quarter, compared to analysts' expectations of $60.39 billion. During the same quarter last year, the company earned $6.47 earnings per share. The firm's revenue was up 14.4% on a year-over-year basis. As a group, equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.
Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd were given a $1.51 dividend. The ex-dividend date of this dividend was Tuesday, June 3rd. This represents a $6.04 annualized dividend and a yield of 1.83%. Cigna Group's dividend payout ratio (DPR) is currently 33.44%.
Wall Street Analysts Forecast Growth
CI has been the subject of a number of recent analyst reports. Cowen reaffirmed a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Truist Financial increased their price objective on Cigna Group from $385.00 to $405.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a research note on Thursday. Barclays restated an "overweight" rating and set a $385.00 price target (up previously from $382.00) on shares of Cigna Group in a research note on Monday, June 2nd. Finally, Wall Street Zen raised shares of Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $380.39.
View Our Latest Research Report on CI
About Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
